Healthcare Vivo Capital Leads $50M Series B Round In Chinese CRO Firm dMed Biopharmaceutical October 16, 2019 — 17:50
Podcasts China VC/Tech Weekly Roundup: China Debuts Shanghai High-Tech Board, Vivo Capital Closes $1.28B Ninth PE Fund June 15, 2019 — 00:10
Fundraising US, Greater China Healthcare-Focused Vivo Capital Garners $1.28B For Ninth PE Fund June 10, 2019 — 12:49
Healthcare Vivo Capital, OrbiMed Lead $80M Series B Round In Biopharmaceutical Start-Up Terns Pharmaceuticals October 31, 2018 — 11:10
